glp 1 drugs sleep apnea GLP-1 Treatment Therapeutic potential of GLP-1RAs in

market, risking drug shortages and price hikes for everyday therapies such as thyroid meds, HRT, and GLP1 treatments

In endothelial progenitor cells (EPC) derived from human peripheral blood mononuclear cells, high glucose conditions downregulate GLP-1-R and sirtuin 1 ( SIRT1 ) expression, leading to impaired cell functions and increased apoptosis via elevated acetylated p53 levels

GLP-1 RAs may attenuate inflammatory response by down-regulating NF-kB signalling

Svensson CK, et al

Support Your GLP-1 Therapy Journey Reduce Side Effects & Maximize Results

The key message for microdosing: Semaglutide delivers benefits across doses